男性不育
支持细胞
精子发生
不育
生物
基因敲除
无精子症
基因传递
基因剔除小鼠
细胞生物学
内科学
内分泌学
遗传增强
男科
癌症研究
医学
基因
遗传学
怀孕
作者
Woo Jin Kim,Bong Soo Kim,Hyun Jung Kim,Young Dan Cho,Hye Lim Shin,Hee In Yoon,Yun Sil Lee,Jeong‐Hwa Baek,Kyung Mi Woo,Hyun‐Mo Ryoo
出处
期刊:ACS Nano
[American Chemical Society]
日期:2020-09-24
卷期号:14 (10): 13217-13231
被引量:14
标识
DOI:10.1021/acsnano.0c04936
摘要
Male infertility is a multifactorial condition. Unexplained male infertility is often caused by spermatogenesis dysfunction. Knockout of Pin1, an important regulator of cell proliferation and differentiation, produces male infertility phenotypes such as testicular immaturity and azoospermia with spermatogonia depletion and blood–testis barrier (BTB) dysfunction. Gene therapy has been clinically considered for the treatment of male infertility, but it is not preferred because of the risks of adverse effects in germ cells. Direct intracellular protein delivery using nanoparticles is considered an effective alternative to gene therapy; however, in vivo testicular protein delivery remains a pressing challenge. Here, we investigated the direct intracellular protein delivery strategy using a fibroin nanoparticle-encapsulated cationic lipid complex (Fibroplex) to restore intratesticular PIN1. Local intratesticular delivery of PIN1 via Fibroplex in Pin1 knockout testes produced fertile mice, achieving recovery from the infertile phenotypes. Mechanistically, PIN1-loaded Fibroplex was successfully delivered into testicular cells, including spermatogonial cells and Sertoli cells, and the sustained release of PIN1 restored the gene expression required for the proliferation of spermatogonial cells and BTB integrity in Pin1 knockout testes. Collectively, testicular PIN1 protein delivery using Fibroplex might be an effective strategy for treating male infertility.
科研通智能强力驱动
Strongly Powered by AbleSci AI